Table 1 Clinical and demographic data.
Patient No/sex | 1/M | 2/M | 3/F | 4/M | 5/M |
Age (y) | 51 | 57 | 64 | 55 | 65 |
Risk factors* | S | 0 | HA, HC, S | HA, S, Cl | S |
Localisation of infarct | Striatocapsular dex | Centrum semiovale dex | Infarcts subcortically sin | Corona radiate sin | Internal capsule dex |
Scan time | Day 4 | Day 1 | Day 2 | Day 3 | Day 4 |
MRC1†/SSS1‡ | 2.30/36 | 3.87/50 | 4.60/54 | 3.92/52 | 2.97/46 |
MRC2/SSS2 | 2.19/36 | 4.55/56 | 5.00/58 | 4.45/56 | 3.97/52 |
MRC3/SSS3 | 2.44/41 | 4.80/58 | 5.00/58 | 4.61/56 | 4.75/55 |
Barthel1¶ | 20 | 70 | 95 | 95 | 60 |
Barthel2 | 50 | 100 | 100 | 100 | 100 |
Barthel3 | 60 | 100 | 100 | 100 | 95 |
MAS1§ | 0 | 6 | 10 | 5 | 1 |
MAS2 | 3 | 15 | 18 | 10 | 10 |
MAS3 | 3 | 18 | 18 | 17 | 12 |
*Cl, Claudicatio intermittens; HA, hypertension arterialis; HC, hypercholesterolaemia; S, smoking.
†MRC, Medical Research Council Scale (0 = no movement, 5 = normal muscle strength), average value of both upper and lower extremities.
‡SSS, Scandinavian Stroke Scale (0–58).
¶Barthel, modified Barthel (0–100).
§MAS, Motor Assessment Scale (upper extremity 0–18).
Neurological scores performed on admission = 1, after 30 days = 2 and after 90 days = 3.